SLS Bio announced on the 2nd that it has decided to enter into a trust contract to acquire its own shares worth 900 million KRW to stabilize its stock price and enhance shareholder value.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing